<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01576458</url>
  </required_header>
  <id_info>
    <org_study_id>73/180/2011</org_study_id>
    <secondary_id>73/180/2011</secondary_id>
    <nct_id>NCT01576458</nct_id>
  </id_info>
  <brief_title>Ursodeoxycholic Acid in the Treatment of Intrahepatic Cholestasis of Pregnancy</brief_title>
  <official_title>Randomised Placebo-controlled Study of Ursodeoxycholic Acid in the Treatment of Intrahepatic Cholestasis of Pregnancy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Turku University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Turku University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine the efficacy and safety of ursodeoxycholic acid
      (UDCA) in the treatment of patients with intrahepatic cholestasis of pregnancy (ICP).

      In the randomised (double-blind, placebo-controlled) study 20 pregnant women with ICP
      received (random allocation of) either 450 mg/day UDCA or placebo for 14 days during the
      third trimester of pregnancy. The severity of pruritus was registered. Itching scores and
      serum levels of alanine aminotransferase, total bile acids, estradiol, progesterone,
      prolactin, cholesterol, HDL-cholesterol, triglycerides, activated partial thromboplastin time
      (APTT), fibrinogen D-dimers (FIDD) and platelet count were assessed before the treatment and
      weekly thereafter. Data on pregnancy and delivery outcome was recorded and analysed.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 1998</start_date>
  <completion_date type="Actual">December 1998</completion_date>
  <primary_completion_date type="Actual">December 1998</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>pruritus</measure>
    <time_frame>an average of 5 weeks</time_frame>
    <description>visual analogy scale (VAS): 0-10</description>
  </primary_outcome>
  <primary_outcome>
    <measure>laboratory values</measure>
    <time_frame>an average 5 weeks</time_frame>
    <description>Serum levels of alanine aminotransferases and total bile acids were assessed before the treatment and once a week thereafter at least three times or until delivery. Simultaneously serum levels of estradiol, progesterone, prolactin, cholesterol, HDL-cholesterol and triglyserides were assessed. Platelet count activated partial thromboplastin time and fibrinogen D-dimers were measured as well.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Obstetrical surveillance</measure>
    <time_frame>2-12 weeks</time_frame>
    <description>Data on pregnancy and delivery outcome was recorded and analysed.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Intrahepatic Cholestasis</condition>
  <condition>Pregnancy</condition>
  <arm_group>
    <arm_group_label>ursodeoxycholic acid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>10 pregant women with intrahepatic cholestasis of pregnancy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>10 pregnant women with intrahepatic cholestasis of pregnancy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ursodeoxycholic acid</intervention_name>
    <description>450 mg/day for 14 days</description>
    <arm_group_label>ursodeoxycholic acid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>placebo</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant women with intrahepatic cholestasis of pregnancy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Susanna Timonen, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Turku University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ulla Ekblad, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Turku University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Riitta Leino, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Turku University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pertti Palo, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Turku University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Turku University Hospital</name>
      <address>
        <city>Turku</city>
        <zip>20520</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>April 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 18, 2012</study_first_submitted>
  <study_first_submitted_qc>April 11, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 12, 2012</study_first_posted>
  <last_update_submitted>April 11, 2012</last_update_submitted>
  <last_update_submitted_qc>April 11, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 12, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Turku University Hospital</investigator_affiliation>
    <investigator_full_name>Titta Joutsiniemi</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>ursodeoxycholic acid</keyword>
  <keyword>intrahepatic cholestasis</keyword>
  <keyword>pregnancy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholestasis</mesh_term>
    <mesh_term>Cholestasis, Intrahepatic</mesh_term>
    <mesh_term>Pregnancy Complications</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ursodeoxycholic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

